European Medicines Agency: Interactive map provides information on studies
The European Medicines Agency provides an interactive map with data from the information system for clinical trials. This is for research purposes.
(Image: EMA)
The European Medicines Agency (EMA) has added an interactive map to its Clinical Trials Information System (CTIS) –, initially in English but with more to follow. The map is designed to provide patients and healthcare professionals with easy access to comprehensive, up-to-date information on clinical trials in their area, thereby encouraging participation in clinical research in the European Union (EU).
The map uses public data from CTIS, improving the user-friendliness of the system and making information on clinical trials more accessible. The map can be used to display ongoing studies in the respective countries. Queries can be made in layman's terms in the search function. It also has an auto-correction system that provides suggestions for spelling errors. The search results also provide information on participation opportunities in specific studies.
Videos by heise
The CTIS contains a publicly searchable database for healthcare professionals, patients and citizens to ensure greater transparency as required by law. The approval and supervision of clinical trials is the responsibility of the Member States of the European Economic Area, the EMA is responsible for the CTIS.
Accelerating clinical trials in the EU
The map is part of the work plan of the initiative to accelerate clinical trials in the European Union. The associated website was published by the EMA in 2023. In 2022, the Clinical Trials Regulation came into force, the implementation of which is monitored by the EU Commission. According to the Federal Office for Drugs and Medical Devices (BfArM), this is intended to "standardize the submission, evaluation and monitoring procedures for clinical trials in the EU via the Clinical Trials Information System [...]".
(mack)
